International Journal of Chemotherapy Research and Practice

International Journal of Chemotherapy Research and Practice

International Journal of Chemotherapy Research and Practice – Editorial Policies

Open Access & Peer-Reviewed

Submit Manuscript
Editorial Integrity

Editorial Policies

Clear policies that protect research integrity

IJCP follows rigorous editorial policies to ensure fairness, transparency, and research integrity across all submissions.

These policies guide peer review, ethics, conflicts of interest, data transparency, and corrections.

Authors, reviewers, and editors share responsibility for upholding these standards at every stage.

Policies align with recognized publishing ethics guidance to protect the credibility of chemotherapy research.

Core Editorial Standards

All manuscripts undergo editorial screening and peer review by subject experts. Decisions are based on methodological quality, originality, and relevance to chemotherapy research and practice.

IJCP requires ethical approval for human and animal studies, disclosure of conflicts of interest, and clear statements on data availability.

Plagiarism screening is performed for all submissions. Suspected misconduct, data fabrication, or duplicate publication is handled in accordance with accepted integrity standards.

Editors may request additional documentation, raw data, or clarifications when integrity concerns arise. Compliance with these requests is required for continued consideration.

Corrections, expressions of concern, or retractions are issued when necessary to protect the accuracy of the scholarly record.

Correction notices clearly describe the issue and link to the original article to maintain transparency for readers and indexers.

Authors should retain primary data and supporting documentation for a reasonable period after publication to enable verification if questions arise.

Preprint posting is permitted when disclosed at submission, and authors should update preprint records after acceptance to link to the final article.

IJCP follows recognized publishing ethics guidance and maintains processes for handling appeals, complaints, and allegations of misconduct in a fair and transparent manner.

Reviewer comments and manuscript content are treated as confidential, and editors must manage conflicts of interest to preserve impartial decision making.

These standards protect authors, reviewers, and readers while maintaining trust in the chemotherapy research record.

Policies are reviewed periodically to reflect changes in ethical guidance, clinical trial standards, and data sharing expectations.

Authors and reviewers are encouraged to raise concerns early so issues can be resolved transparently and fairly.

We follow COPE guidance for ethical case handling and corrections.

Authorship disputes are handled with documented contributor roles and institutional guidance when needed.

Ethical breaches may result in rejection, correction, or retraction with public notice. Transparency is essential for trust.

Peer Review

Double blind peer review is used when possible. Editors select reviewers for expertise and lack of conflicts.

Ethics and Consent

Human studies must include IRB approval and informed consent. Animal studies must follow accepted welfare guidelines.

Conflicts of Interest

Authors, reviewers, and editors must disclose financial or professional conflicts that could influence judgment.

Corrections and Retractions

Significant errors are corrected through published notices. Retractions follow established integrity guidelines.

Appeals and Complaints

Authors may appeal decisions with clear scientific justification. Complaints are reviewed by editorial leadership.

Data Transparency

Authors must include data availability statements and provide supporting documentation when required.

Policy Areas

01

Authorship

All listed authors must meet contribution standards and approve the final manuscript.

02

Originality

Submissions must be original and not under review elsewhere.

03

Data Integrity

Data should be accurate, complete, and available per stated policies.

04

Clinical Trials

Trials must be registered in an approved registry.

05

Appeals

Authors may appeal decisions with clear scientific justification.

06

Misconduct

Allegations of misconduct are investigated according to publishing ethics standards.

07

Confidentiality

Reviewer comments and manuscript content remain confidential throughout review.

08

Corrections

Published corrections maintain transparency and accuracy when errors are identified.

Compliance Expectations

These standards protect authors and maintain the integrity of the scholarly record.

Required
Conflict Disclosure
Mandatory
All authors
Transparency
Required
Data Statement
Mandatory
All manuscripts
Reproducible

Editorial Commitment

Fair Review

Decisions based on scientific merit and relevance.

🔐

Ethical Safety

Protection of participants and responsible research conduct.

📰

Transparency

Clear disclosure and data availability expectations.

Corrections

Published notices maintain record accuracy.

Trustworthy Publishing

Clear policies strengthen confidence in published chemotherapy research and protect the integrity of clinical evidence. Transparent standards reduce disputes and improve long term credibility while supporting fair editorial decisions.

Questions About Policies?

Contact the editorial office for clarification before submission.

[email protected]

Submit Your Manuscript

Publish with rigorous editorial standards and open access visibility.